These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antimicrobial resistance trends among canine Escherichia coli isolated at a New York veterinary diagnostic laboratory between 2007 and 2020. Osman M, Albarracin B, Altier C, Gröhn YT, Cazer C. Prev Vet Med; 2022 Nov; 208():105767. PubMed ID: 36181749 [Abstract] [Full Text] [Related]
9. Veterinary Hospital Dissemination of CTX-M-15 Extended-Spectrum Beta-Lactamase-Producing Escherichia coli ST410 in the United Kingdom. Timofte D, Maciuca IE, Williams NJ, Wattret A, Schmidt V. Microb Drug Resist; 2016 Oct; 22(7):609-615. PubMed ID: 27314838 [Abstract] [Full Text] [Related]
10. Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States. Shaheen BW, Nayak R, Foley SL, Kweon O, Deck J, Park M, Rafii F, Boothe DM. Antimicrob Agents Chemother; 2011 Dec; 55(12):5666-75. PubMed ID: 21947397 [Abstract] [Full Text] [Related]
12. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones. Gottlieb S, Wigney DI, Martin PA, Norris JM, Malik R, Govendir M. Aust Vet J; 2008 Apr; 86(4):147-52. PubMed ID: 18363989 [Abstract] [Full Text] [Related]
16. Prevalence of antimicrobial resistance in relation to virulence genes and phylogenetic origins among urogenital Escherichia coli isolates from dogs and cats in Japan. Harada K, Niina A, Nakai Y, Kataoka Y, Takahashi T. Am J Vet Res; 2012 Mar; 73(3):409-17. PubMed ID: 22369535 [Abstract] [Full Text] [Related]
17. Reduced rates of antimicrobial resistance in Staphylococcus intermedius group and Escherichia coli isolated from diseased companion animals in an animal hospital after restriction of antimicrobial use. Kurita G, Tsuyuki Y, Murata Y, Takahashi T, Veterinary Infection Control Association (VICA) AMR Working Group. J Infect Chemother; 2019 Jul; 25(7):531-536. PubMed ID: 30905629 [Abstract] [Full Text] [Related]
18. In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine. Bennie CJ, To JL, Martin PA, Govendir M. Aust Vet J; 2015 Jul; 93(1-2):40-5. PubMed ID: 25622709 [Abstract] [Full Text] [Related]
19. Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections. Cooke CL, Singer RS, Jang SS, Hirsh DC. J Am Vet Med Assoc; 2002 Jan 15; 220(2):190-2. PubMed ID: 12126128 [Abstract] [Full Text] [Related]
20. Antimicrobial resistance and pharmacodynamics of canine and feline pathogenic E. coli in the United States. Boothe D, Smaha T, Carpenter DM, Shaheen B, Hatchcock T. J Am Anim Hosp Assoc; 2012 Jan 15; 48(6):379-89. PubMed ID: 23033458 [Abstract] [Full Text] [Related] Page: [Next] [New Search]